Loading organizations...
§ Private Profile · Hyderabad, India
Chronic disease management platform providing subscription-based discounted medicines and expert consultations for chronic disease patients.
Digi-Prex has raised $6.0M across 1 funding round.
Key people at Digi-Prex.
Digi-Prex was founded in 2019 by Samarth Sindhi (Founder).
Digi-Prex has raised $6.0M in total across 1 funding round.
Digi-Prex is a chronic disease management platform and e-pharmacy that provides subscription-based access to discounted, home-delivered medications, operating primarily out of Hyderabad, India. The company offers a holistic health solution that includes unlimited expert consultations and customized treatment plans for conditions such as hair loss, sexual health, weight management, and skincare. Operating with an estimated workforce of 20 to 200 employees, the healthtech startup has raised approximately $6.75 million in total funding to scale its digital healthcare services. Digi-Prex is backed by prominent venture capital firms including Khosla Ventures, Quiet Capital, and W Health Ventures, and was also selected to participate in the Y Combinator accelerator program. The organization operates the subsidiary Good Health Clinic and later rebranded its core platform to Raksha Health to reflect its expanded clinical offerings. Digi-Prex was founded in 2019 by Samarth Sindhi.
Digi-Prex has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Seed in September 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2019 | $6M Seed | — | 1984 Ventures, DST Global, Goat Capital, Greenoaks Capital, Hack VC, Locus Ventures, Meritech Capital Partners, Rucker Park Capital, The House Fund, Turtle Ventures, Vibe Capital, VU Venture Partners, What IF Ventures, Daniel KAN, Gabriel Jarrosson, Kenji Niwa, Marty Weiss, Mathieu Guerville, Nirbhay Dhapodkar, Sung HO Choi, Tirto Adji, Travis Vanderzanden, William Hockey, Justin Mateen, Khosla Ventures, Quiet Capital, SV Angel, Vedanta Capital, Y Combinator | Announced |
Digi-Prex was founded in 2019 by Samarth Sindhi (Founder).
Digi-Prex has raised $6.0M in total across 1 funding round.
Digi-Prex's investors include 1984 Ventures, DST Global, Goat Capital, Greenoaks Capital, Hack VC, Locus Ventures, Meritech Capital Partners, Rucker Park Capital, The House Fund, Turtle Ventures, Vibe Capital, VU Venture Partners.
Digi-Prex is a subscription pharmacy platform based in Hyderabad, India, specializing in delivering medications to patients with chronic diseases such as diabetes, hypertension, asthma, and heart disease. It offers a streamlined, automated medication refill service that ensures consistent access to essential medicines, improving adherence to long-term treatment plans. By focusing exclusively on chronic disease management, Digi-Prex differentiates itself from general e-pharmacies, targeting a high-need, recurring customer base with discounted medicines delivered free to the doorstep[1][2][3].
The platform serves patients who require ongoing medication, including elderly individuals and families managing multiple prescriptions. Digi-Prex uses AI-driven lifestyle management solutions alongside its pharmacy service to provide a holistic care experience. Its subscription model reduces the risk of missed doses and simplifies medication management, addressing a critical gap in India’s fragmented pharmacy access landscape[1][2][4].
Founded in 2019 by Samarth Sindhi, an alumnus of Brown University with prior healthcare experience in the U.S., Digi-Prex emerged from the recognition of challenges faced by chronic disease patients in India regarding medication adherence and access. Sindhi observed the widespread use of WhatsApp in India and leveraged it as a communication channel for prescription sharing and customer engagement. Early traction came from Hyderabad, where Digi-Prex quickly amassed thousands of customers by partnering with physicians and pharmacies rather than relying solely on online customer acquisition. This collaborative model helped the startup serve patients in distant neighborhoods effectively[2][4][6][7].
Digi-Prex rides the growing trend of digital health and subscription-based healthcare services, particularly in emerging markets like India where chronic diseases are rising rapidly. The timing is critical as India faces a large and increasing burden of chronic illnesses with fragmented healthcare infrastructure. Digi-Prex’s model leverages mobile technology (WhatsApp) and AI to improve medication adherence and patient outcomes, addressing a significant unmet need. Its approach also exemplifies how digital platforms can integrate with traditional healthcare providers to create scalable, patient-centric solutions. This contributes to the broader ecosystem by demonstrating sustainable models for chronic disease management in low- and middle-income countries[1][2][4].
Digi-Prex is positioned to expand beyond Hyderabad to multiple Indian cities, scaling its subscription pharmacy and holistic care model. Future growth will likely be driven by deeper integration of AI for personalized care, expanded partnerships with healthcare providers, and enhanced patient engagement tools. As chronic disease prevalence grows, Digi-Prex’s influence could extend to shaping how digital health platforms support long-term medication adherence and lifestyle management in emerging markets. Its success may inspire similar models globally, emphasizing the importance of convenience, affordability, and technology-enabled care continuity for chronic disease patients[4][7].
Key people at Digi-Prex.
